Therapies

Aridis Pharmaceuticals Announces 2019 Fourth Quarter and Year-End Financial Results and Business Update

6 hours ago   |   San Diego Biotechnology   |   2 articles

SAN JOSE, Calif., April 8, 2020 /PRNewswire/ - Aridis Pharmaceuticals, Inc. , a biopharmaceutical company focused on the discovery and development of novel anti-infective...
Read more ...

Premier Biomedical, Halberd and Gold River Agree to Work Jointly to Develop Premier's Patented Extracorporeal Technology on COVID-19 Treatment And Proprietary Anti-Addiction PatchTM

6 hours ago   |   Premier Biomedical   |   2 articles

Jackson Center, PA, April 8, 2020 - Premier Biomedical, Inc. , Halberd Corporation and Gold River Productions Inc. announce the signing of a multi-faceted agreement for ongoing...
Read more ...

UC San Diego to Advance Stem Cell Therapies in New Space Station Lab

6 hours ago   |   San Diego Biotechnology


Read more ...

Tackling COVID-19 with the help of the virus that causes kennel cough in dogs

14 hours ago   |   Fierce Biotech   |   2 articles

Scientists have been using viruses to deliver gene therapies or vaccines. Now, researchers at the University of Iowa and the University of Georgia are suggesting the virus that...
Read more ...

Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13

Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13

1 day ago   |   Xconomy

In the Boston biotech hub, much progress has been made advancing digital health, but significant scientific, technological, financial, and regulatory challenges remain. Join us...
Read more ...

Evotec allies with Takeda to move into gene therapy R&D

1 day ago   |   Fierce Biotech

Evotec has allied with Takeda to expand into gene therapy research. The move sees Evotec establish a 20-person team in Austria, the focal point of Takeda's gene therapy...
Read more ...

Viking Therapeutics to Participate in 19th Annual Needham Healthcare Conference

1 day ago   |   San Diego Biotechnology

SAN DIEGO, April 7, 2020 /PRNewswire/ - Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and...
Read more ...

Convalescent Plasma: A Therapy for COVID-19?

Convalescent Plasma: A Therapy for COVID-19?

2 days ago   |   Discovery's Edge   |   2 articles

To develop a treatment for patients with COVID-19, researchers around the world are steadfastly exploring numerous angles, including testing existing antiviral drugs and new...
Read more ...

GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months

GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months

2 days ago   |   Xconomy

GlaxoSmithKline has agreed to invest $250 million in infectious disease specialist Vir Biotechnology to launch a COVID-19 R&D alliance that the companies say could advance two...
Read more ...

AveXis Inc.: Manager, Research Quality Assurance

2 days ago   |   San Diego Biotechnology   |   3 articles

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests

Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests

The financial markets may remain volatile but Keros Therapeutics managed to raise more money in its public market debut than it had initially planned. Late Tuesday the... Read more ...

Gilead Heightens Inflammatory Disease Focus With Second Genome Microbiome Deal

Gilead Heightens Inflammatory Disease Focus With Second Genome Microbiome Deal

Gilead Sciences has signed an agreement with South San Francisco biotech Second Genome to use its microbiome drug development expertise to advance the compounds it is... Read more ...

Organovo Future Unclear After Shareholders Reject Tarveda Merger

Organovo Future Unclear After Shareholders Reject Tarveda Merger

A planned merger between struggling 3-D “bioprinter” Organovo and Tarveda Therapeutics, a privately held cancer drug developer looking to join the public markets through a... Read more ...

In Battle Against COVID-19 Pandemic, Scientists Turn to PacBio Sequencing

In Battle Against COVID-19 Pandemic, Scientists Turn to PacBio Sequencing

Image by Miroslava Chrienova from Pixabay Our team is proud to announce that PacBio has been working closely with customers to help in the fight against the COVID-19 pandemic... Read more ...

Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics

Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics

Some diseases have proven difficult to address using conventional tools of drug discovery that target disease-causing proteins. Roche is placing a $190 million bet on Arrakis... Read more ...

Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers

Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers

Inovio Pharmaceuticals, one of the biotechs developing a vaccine to prevent COVID-19, has received the FDA's OK to start testing its candidate in healthy volunteers. The... Read more ...

Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug

Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug

Sage Therapeutics is cutting workers who sell its only commercialized drug in a corporate reorganization that it says allows it to focus on clinical-stage compounds, including... Read more ...

Creating Consistent Value in Biotech Without Diluting Stakeholders

Creating Consistent Value in Biotech Without Diluting Stakeholders

One of the greatest challenges for pre-commercial biotech companies is consistently generating capital necessary for operating costs and for R&D of new products that provide... Read more ...

Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13

Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13

In the Boston biotech hub, much progress has been made advancing digital health, but significant scientific, technological, financial, and regulatory challenges remain. Join us... Read more ...

Methylation-driven model for analysis of dinucleotide evolution in genomes

CpGs, the major methylation sites in vertebrate genomes, exhibit a high mutation rate from the methylated form of CpG to TpG/CpA and, therefore, influence the evolution of... Read more ...